Schizophrenia is associated with deficits in cortical plasticity that affect sensory brain regions and lead to impaired cognitive performance. Here we examined underlying neural mechanisms of auditory plasticity deficits using combined behavioural and neurophysiological assessment, along with neuropharmacological manipulation targeted at the N-methyl-D-aspartate type glutamate receptor (NMDAR). Cortical plasticity was assessed in a cohort of 40 schizophrenia/schizoaffective patients relative to 42 healthy control subjects using a fixed reference tone auditory plasticity task. In a second cohort (n = 21 schizophrenia/schizoaffective patients, n = 13 healthy controls), event-related potential and event-related time-frequency measures of auditory dysfunction were assessed during administration of the NMDAR agonist D-serine. Mismatch negativity was used as a functional read-out of auditory-level function. Clinical trials registration numbers were NCT01474395/NCT02156908. Schizophrenia/schizoaffective patients showed significantly reduced auditory plasticity versus healthy controls (P = 0.001) that correlated with measures of cognitive, occupational and social dysfunction. In event-related potential/time-frequency analyses, patients showed highly significant reductions in sensory N1 that reflected underlying impairments in y responses (P 5 0.001), along with reduced y and b-power modulation during retention and motor-preparation intervals. Repeated administration of D-serine led to intercorrelated improvements in (i) auditory plasticity (P 5 0.001); (ii) y-frequency response (P 5 0.05); and (iii) mismatch negativity generation to trained versus untrained tones (P = 0.02). Schizophrenia/schizoaffective patients show highly significant deficits in auditory plasticity that contribute to cognitive, occupational and social dysfunction. D-serine studies suggest first that NMDAR dysfunction may contribute to underlying cortical plasticity deficits and, second, that repeated NMDAR agonist administration may enhance cortical plasticity in schizophrenia.
Introduction
Deficits in cognitive function are amongst the strongest predictors of impaired functional outcome in schizophrenia (Bowie et al., 2006) , including reduced cortical plasticity in tasks designed to produce learning, leading to impaired benefits from cognitive remediation (Green et al., 2012) . Although paradigms for assessment of ongoing cognitive impairment are well-established, relatively few paradigms are presently available for specific assessment of cortical plasticity Vinogradov et al., 2012; Popov et al., 2015; Kantrowitz et al., 2016) . In general, brain N-methyl-D-aspartate-type glutamate receptors (NMDARs) are known to play a crucial role in both cortical plasticity mechanisms (Burgos-Robles et al., 2007) and the pathophysiology of schizophrenia (Krystal et al., 1994) .
In the auditory system, patients with schizophrenia show well described impairments in tone-matching ability that contribute directly to higher order functional impairments in processes such as reading, auditory emotion recognition and theory of mind (Javitt and Freedman, 2015) . Patients with schizophrenia also show impaired generation of auditory event-related potential (ERP) measures such as mismatch negativity (MMN) and auditory N1 that reflect impairment of NMDAR function at the level of auditory sensory cortex (Javitt et al., 1996; Gunduz-Bruce et al., 2012; Gil-da-Costa et al., 2013; Todd et al., 2013) . The concept that auditory plasticity should be impaired as well in schizophrenia is supported by the general ability of NMDAR to serve as critical triggers for plasticity-related functions such as long-term potentiation and depression in cortex (Javitt and Zukin, 1991; Hunt and Castillo, 2012; Luscher and Malenka, 2012) . Nevertheless, this is the first study of which we are aware to investigate either integrity of auditory plasticity in schizophrenia or its relationship to underlying NMDAR dysfunction.
The present report describes results of three interrelated studies that investigated the neurophysiological and NMDAR-related mechanisms of auditory cortical plasticity in schizophrenia. All studies used an adaptive tone-matching task originally developed for investigation of auditory dysfunction in developmental dyslexia (Ahissar et al., 2006) . In this task, subjects listen to a repeated series of tone pairs and state whether the second stimulus ('test tone', S2) is higher or lower in pitch than the first stimulus ('reference tone,' S1). The difference in frequency (Áf) between reference and test tones is continuously adjusted during the task using a 'two-down/one-up' rule to maintain a consistent ($70% correct) level of performance. The task is implemented in both a 'random' condition in which the S1 stimulus varied randomly over trials, and a 'fixed' condition in which S1 remained constant.
In the random condition, no auditory learning ('plasticity') occurs, so that performance remains stable over repeated trials. By contrast, in the fixed condition, improvement (learning) occurs, presumably reflecting plastic change at the level of auditory cortex. Across studies, the just-noticeable difference (JND) threshold at the end of the random/fixed titration periods, expressed as per cent change in frequency between the S1 and S2 stimuli (%Áf) serves as the primary outcome variable. Withinsession improvement (i.e. plasticity) served as a secondary measure.
In our first study, we first evaluated performance on the adaptive tone-matching task relative to other cognitive functions in an initial cohort of stabilized schizophrenia subjects. Based on these behavioural findings, we next evaluated underlying neurophysiological processes using time-domain (ERP) and time-frequency decomposition of neurophysiological data. Finally, to test the potential involvement of NMDAR, we administered the NMDAR agonist D-serine during repeated testing. Although we use the adaptive tone-matching test primarily to assess mechanisms underlying cortical learning (plasticity) deficits in schizophrenia, we note that other processes such as motivation, arousal, attention and alertness may also affect performance. Although the present study targets the auditory system specifically, impaired plasticity is felt to be a core deficit in schizophrenia across cortical systems.
Behavioural assessment of auditory plasticity
In developmental dyslexia, deficits are observed primarily in the fixed condition and correlate with impaired reading and working memory (Ahissar et al., 2006) . By contrast, performance in the random condition is relatively preserved. Deficits in developmental dyslexia are interpreted relative to the Reverse Hierarchical Theory, which posits that patients with dyslexia are particularly impaired when high-level brain regions must gain access to lower level representations, as occurs in the fixed condition (Ahissar et al., 2009) . Critical substrates for the fixed versus random conditions have also been investigated using functional MRI. In general, the random and fixed conditions rely on primary auditory cortical function to a similar degree. However, the random condition activates frontoparietal regions to a greater extent, while the fixed condition modulates activity primarily in posterior regions of superior temporal cortex and left intrapartietal regions (Daikhin and Ahissar, 2015) .
We have previously observed deficits in tone-matching in schizophrenia using tasks equivalent to the 'random' condition of the adaptive tone-matching task used in the present study. Such deficits, moreover, are associated with impairments in neurophysiological processing at the level of auditory cortex as indexed by processes such as MMN . We have also recently observed that patients show severe deficits in reading ability that appear to develop following illness onset (Revheim et al., 2014) .
In the present study, we evaluated performance on the fixed and random versions of the task in order to evaluate integrity of auditory plasticity along with simpler tonematching ability. We hypothesized first that patients with schizophrenia would also show deficits in auditory plasticity compared with healthy controls over and above their previously reported tone-matching impairments, and second that these deficits would additionally correlate with reading impairment and other measures of academic and social function as in developmental dyslexia.
Neural mechanisms of auditory plasticity impairments
Following our behaviour study, we conducted a second study in a new cohort of subjects to address neural mechanisms underlying the behavioural deficits using neurophysiological (ERP/time-frequency) measures. In general, ERP have proven to be effective for evaluation of neural mechanisms underlying sensory/cognitive dysfunction in schizophrenia. Deficits in the generation of cognitionrelated ERP were first demonstrated over 40 years ago and shown to reflect dysfunction within frontoparietal brain regions (Small and Small, 1971; Roth and Cannon, 1972) . Deficits in MMN generation were first demonstrated over 20 years ago (Shelley et al., 1991) , and have been shown to reflect NMDAR dysfunction at the level of primary auditory cortex. Impairments are observed as well in other auditory sensory potentials such as N1/P2 (Roth and Cannon, 1972; Crowley and Colrain, 2004) , further suggestive of auditory-level dysfunction.
More recently, time-frequency decomposition approaches have been used to extract further information from neurophysiological studies. In this approach, event-related activity is first resolved into underlying frequency bins prior to averaging, including d (1-4 Hz), y (4-7 Hz), a (7-12 Hz), b (12-30 Hz) and g (430 Hz). For example, deficits in MMN and N1 map to y Lakatos et al., 2013) , which may index function of networks involving somatostatin (SST)-type interneurons (Womelsdorf et al., 2014; Javitt and Sweet, 2015) . By contrast, deficits in P300 are associated with impaired d entrainment (Lakatos et al., 2013) . g-band deficits are widely associated with impaired function of networks incorporating parvalbumin interneurons (Gonzalez-Burgos and Lewis, 2012; Womelsdorf et al., 2014) . In addition to event-locked ('evoked') power, time-frequency analyses also provide separate measures for intertrial coherence (ITC), which reflects phase reset mechanisms.
The adaptive tone-matching task used in the present study elicits a characteristic N1/P2 response complex that indexes activation at the level of primary and secondary auditory regions, as well as a contingent negative variation (CNV) component that indexes frontal dysfunction. In dyslexia, significant deficits are observed in generation of P2 but not of other components, consistent with top-down theories of auditory dysfunction. In the present study, we evaluated integrity of N1/P2/CNV generation, along with integrity of time-frequency measures such as y-modulation to stimulus presentation, to gain insights into neural mechanisms underlying auditory impairments in schizophrenia.
Role of NMDAR dysfunction in auditory plasticity deficits in schizophrenia Finally, we evaluated the effects of the NMDAR agonist D-serine on our behavioural and neurophysiological measures. As previously reviewed Javitt, 2009, 2010) , NMDAR dysfunction may play a critical role in the pathophysiological mechanisms associated with schizophrenia, and may underlie impairments in MMN generation and other neurophysiological processes. In turn, treatment with NMDAR agonists, such as D-serine, may lead to improvement in symptoms and MMN generation (Kantrowitz et al., submitted for publication), although ideal use of such compounds in clinical situations remains to be determined.
One mechanism by which NMDAR agonists may aid symptoms of schizophrenia and other disorders is by enhancement of cortical plasticity. Thus, the NMDAR partial agonist D-cycloserine has been used to augment cognitive behaviour therapy in anxiety disorders and schizophrenia, particularly when used repeatedly at intervals of 51 week (Javitt, 2013; Ori et al., 2015; Goff, 2016) . Similarly, Dserine has been shown to modulate plasticity in both healthy volunteers (Levin et al., 2015) and older adults (Avellar et al., 2016) .
Here, we used an intermittent treatment design with three sessions of interleaved D-serine and placebo treatment in patients with schizophrenia, conducted in a primary double-blind study (n = 13) and an additional open-label study (n = 8) to further assess ERP/time-frequency effects.
We hypothesized that D-serine would significantly enhance auditory plasticity and neurophysiological function, and that greatest effects would be observed after repeated D-serine treatment, consistent with recent Dcycloserine findings (Cain et al., 2014) . Based on previous studies (Kantrowitz et al. , submitted for publication), we primarily predicted improvement in MMN, but also assessed D-serine effects on time-frequency during the auditory plasticity session.
Materials and methods

Subjects
All subjects were recruited from the Nathan Kline Institute (NKI) and signed written informed consent. Patients met criteria for either schizophrenia or schizoaffective disorder, while healthy controls had no history of a major Axis I disorder. Exclusion criteria were neurological/sensory disorders noted on medical history, substance dependence (44 months) and/or abuse (1 month) or an IQ 4 85. Patients with schizophrenia receiving D-serine were excluded for unstable medical illness, glomerular filtration rate (GFR) 5 60, treatment with clozapine or psychotropic medication changes within 44 weeks.
Design
Across the three interrelated studies, subjects were presented with paired tones (S1/S2) and asked to indicate which tone was higher in pitch. All subjects completed a practice block of 10 pairs.
Duration of tones was 50 ms and the interstimulus interval was 950 ms, presented at a comfortable volume. The intertrial interval was dependent on subject response. In the first pair, the ratio was 50% (e.g. 1000 versus 1500 or 500 Hz). A twodown/one-up staircase procedure was used to adjust the ratio, with step-size beginning at 40 Hz and decreasing, over the course of the session, to 5 Hz. In all studies, ratios in each pair were log-transformed and averaged across 10-trial pairs (e.g. pairs 1-10, 11-20, etc.) to create the tone-matching thresholds (JND), which served as the primary outcome measure. Within session improvement (change from trials 20-30 versus 70-80, e.g. plasticity) and across session change in JND (change between sessions) served as secondary outcomes.
Behavioural study
In the behavioural study, we evaluated clinical correlates of auditory plasticity dysfunction in schizophrenia using random (S1 was chosen at random between 250-4000 Hz) and fixedanchor (S1 was fixed at 1000 Hz) conditions. Forty patients with schizophrenia and 42 healthy controls completed one session of auditory plasticity assessments only, including two random and two fixed repetitions in a randomized order (behavioural study: Table 1 and Fig. 1A ). Auditory emotion recognition, Wechsler Adult Intelligence Scale-III (WAIS-III), tone-matching task and Comprehensive Test of Phonological Processing -Alternate Phonological Awareness (CTOPP-APA) tasks were assessed (Wechsler, 1997; Wagner et al., 1999; Gold et al., 2012) .
Neurophysiological and NMDAR studies
In the neurophysiological and NMDAR mechanisms studies, 21 additional patients with schizophrenia underwent neurophysiological assessments AE D-serine during three weekly auditory plasticity assessment sessions versus 13 healthy controls completing one session each (Table 1 and Fig. 1B) . Doubleblind patients with schizophrenia (n = 13) had two D-serine treatment sessions and one placebo session, in a randomized, counter-balanced order. Open label patients with schizophrenia received three sessions with either D-serine (n = 5) or no intervention (n = 3). Subjects underwent three 80-tone pair repetitions of the fixed-anchor condition per session, with the Parental socioeconomic status information was not available for 17 patients and three controls. Education data (and therefore individual socioeconomic status) were unavailable for five patients and two controls. Age at first hospitalization was unavailable for five patients. Positive and Negative Syndrome Scale (PANSS) was unavailable for eight patients. Antipsychotic dose is listed as chlorpromazine (CPZ) equivalents (Woods, 2003) . Receiving at least one adjunctive medication with anticholinergic properties (benztropine, trihexyphenidyl or diphenhydramine) *P 5 0.05 trained tone (S1 Hz: 500, 1000, or 2000 Hz) assigned in a random order across sessions.
EEG recordings
Continuous EEG data were collected from 64 scalp electrodes using Advanced Neurotechnology (ANT) digital recording system with previously reported methods (Friedman et al., 2012) . ERP analysis was performed offline using MATLAB (2013a, Mathworks, Natick, MA) and BESA (BESA GmbH, Grä felfing, Germany). Data were examined for eye, facial muscle and residual artefacts, which were removed using independent components analysis (EEGLAB 10.2.2.0 b) (Delorme and Makeig, 2004) . A 0.1-100 Hz filter was applied, along with a 60 Hz line noise filter, and the electrode information was rereferenced to the average linked mastoids. Trials with amplitudes that exceeded AE 90 mV were removed. Occasional noisy channels were substituted by interpolated data from neighbouring channels.
Auditory plasticity
Epochs were defined from À200 ms to 1500 ms. Responses were averaged over six electrodes centred on FCz (FC1, FCz, FC2, C1, Cz, C2).
Event-related potential analysis
Data were high-pass filtered at 1 Hz zero-phase 24 dB/oct and low-pass filtered at 15 Hz zero-phase 24 dB/oct. Mean amplitudes were calculated centred around the control peaks for N1 ( AE 40 ms), P2 ( AE 45 ms), P2b to S1 (375-400 ms) and for the CNV (1000-1150 ms).
Time-frequency analysis
The signal in each individual trial was decomposed into the time-frequency domain using the complex demodulation procedure implemented in BESA for a frequency window of 4-50 Hz. Frequencies were sampled in 2-Hz steps, and time in 200-ms steps. Further analysis was performed using MATLAB (Mathworks, Natick, MA), with Fieldtrip (http://www.ru.nl/ fcdonders/fieldtrip/) and custom written scripts.
Time-frequency analyses were focused on three time windows (Dias et al., 2013; Bickel et al., 2012) . A sensory response period (0-200 ms post-S1 and S2), was meant to capture the initial sensory volley of activity, corresponding to the N1 response; a retention interval between S1 and S2 (400-1000 ms) was meant to capture the encoding activity; and a motor-preparation interval (200-500 ms post-S2) captured the activity in preparation of a response. Frequency boundaries were: y (4-7 Hz), a (7-12 Hz), b (12-30 Hz). We did not analyse the data above 30 Hz. Time-frequency data were arctangent-corrected before statistical analysis for normalization. Neurophysiology was recorded during auditory plasticity sessions, followed by post-treatment MMN. Each patients with schizophrenia subject completed three sessions, $1 week apart, while healthy controls (HC, n = 13) completed one session each without D-serine. Usable behavioural (auditory plasticity) data were available from all 21 patients with schizophrenia, yielding 63 schizophrenia sessions (three per subject) and 13 healthy controls (one session each, 13 total sessions). A portion of time-frequency and EEG data were excluded for poor data quality. Time-frequency data were excluded from 2 of 13 healthy control sessions (yielding 11 remaining) and 11 patients with schizophrenia sessions (yielding 52 remaining). 
Mismatch negativity
MMN was obtained to pitch deviant stimuli pre-post auditory plasticity training, utilizing deviants to the same base frequencies as the auditory plasticity sessions, (i.e. 500, 1000, and 2000 Hz), with $10 min of each base frequency. Epochs were defined from À300 to 500 ms. Epochs were then averaged for each stimulus separately to generate ERPs and highpass filtered at 0.5 Hz forward-phase 6 dB/oct and low-pass filtered at 40 Hz zero-phase 48 dB/oct. Responses were averaged over 12 electrodes (AF3, AFz, AF4, F1, Fz, F2, FC1, FCz, FC2, C1, Cz, C2) centred on FCz. Pre and post-amplitudes and within-day change was calculated across 50-200 ms for all tones and within session trained tone.
Antipsychotics
Chlorpromazine equivalents (Woods, 2003) are noted in Table 1 . A minority were receiving adjunctive anticholinergics (Table 1) , and 70% were receiving antipsychotics with known anticholinergic properties (clozapine, chlorpromazine, olanzapine, quetiapine).
Statistical analysis
Subjects were compared between groups with respect to baseline characteristics using parametric (e.g. t-test) or nonparametric (e.g.
2 ) tests as appropriate. Linear, mixed effects models were used to accommodate correlated responses of subjects across trials (e.g. trials 1-10, 11-20, etc.) and session (treatment day: 1, 2 and 3).
Primary analyses evaluated healthy controls versus patients with schizophrenia receiving no intervention or placebo, while a secondary analysis evaluated the effects of D-serine. Outcomes were modelled as functions of group (controls, placebo, one consecutive session of D-serine or two consecutive sessions of D-serine), session, trial (auditory plasticity analysis only) and blind (double-blind or open-label). Time-frequency analysis was conducted separately by time window and frequency band. MMN analyses were conducted both across all tones and within the trained tones.
Between-group differences were analysed using mixed model ANOVA with Sidak adjustments to correct for multiple comparisons. After assessing for group by covariate interactions with an ANCOVA, Pearson correlations and linear regression with correction for group membership was used to compare relationships among variables. As detailed in the results and Table 2 , there were no significant Group Â Predictor interactions for across group correlations, which remained significant after control for group (partial r) without modelling for a Group Â Predictor interaction. Values in the text are mean AE standard deviation (SD) unless otherwise specified.
Results
Behavioural auditory plasticity deficits in schizophrenia
This study included 40 patients with schizophrenia versus 42 healthy controls (Table 1 and Fig. 1A ). As expected, in the random condition ( Fig. 2A) , both groups reached stable performance levels by Trials 20-30 with no significant further change by the titration endpoint (Trials 70-80, both P 4 0.26). By contrast, in the fixed condition (Fig. 2B ) both groups showed continued improvement throughout the titration period (both P 5 0.001) reflecting additional plasticity from repeated presentation of the fixed reference tone.
Patients with schizophrenia showed highly significant reductions in performance across both random and fixed conditions [F(1,80) = 16.4, P 5 0.0001] (Fig. 2C) . The Group Â Condition interaction was also significant Fig. 2D ], reflecting impaired plasticity along with impaired baseline tone-matching.
Relationship to function
As expected, patients with schizophrenia showed significant deficits across a range of cognitive processes related to social and occupational function (Table 2) . After control for group, deficits in thresholds during the fixed condition correlated significantly with deficits in working memory (Fig. 2E) , auditory emotion recognition (Fig. 2F ) and phonological reading ability (Fig. 2G) , along with perceptual organization (partial r = À0.45, P 5 0.0001), without any Group Â Cognitive process interaction (Table 2) . Correlations remained significant within patients with schizophrenia alone. While similar correlations were seen with the final random JND (all P 5 0.0001) using Pearson correlations, the random condition was not independently significant after control for the fixed condition. By contrast, the fixed condition remained independently significant/ trend level correlated (all P 5 0.062) except for reading.
Neurophysiological mechanism of auditory plasticity deficits in schizophrenia
A second experiment investigated neurophysiological correlates of impaired auditory plasticity in a separate cohort (Supplementary material, Table 1 and Fig. 1B) . Because of time considerations, data were obtained from the fixed condition only. The procedure and available data for auditory plasticity, time-frequency and MMN for each subgroup are noted in Fig. 1 . Linear, mixed effects modelling was used to accommodate correlated responses of subjects across sessions.
Activity pattern in healthy controls
ERP ( Fig. 3A and Supplementary Table 1 ) results and measured amplitudes were consistent with prior studies using this task (Nahum et al., 2010; Cohen et al., 2013; JaffeDax et al., 2015) , with an N1/P2 complex to both S1 and S2 stimuli, and a CNV during the 1000-1150 ms interval, leading to negative displacement of the S2 N1/P2 response.
Consistent with prior studies using visual paired stimulus-matching tasks (Bickel et al., 2012; Dias et al., 2013) , time-frequency (Fig. 3B) responses consisted of three main components: (i) sensory responses immediately following the S1 (0-200 ms) and S2 (1000-1200 ms) stimuli; (ii) a 'retention interval' response that occurred between the S1 and S2 stimuli (400-1000 ms); and (iii) a 'motorpreparation' interval that occurred following the S2 response (1200-1500 ms).
The sensory responses to S1 and S2 stimuli were characterized by increases in y/a activity that were evident both in ITC and power. During the retention interval, activity was characterized primarily by a non-phase locked ('induced') suppression of ongoing y and b activity (y and b-ERD). Finally, during the motor preparation interval, activity was associated with an increase in y-ITC along with suppression of ongoing b activity (b-ERD).
Activity patterns in patients with schizophrenia
Comparisons were made with patients with schizophrenia not receiving pharmacological intervention pre-session (i.e. n = 16 placebo sessions). Patients with schizophrenia showed similar overall ERP (Fig. 3A) and time-frequency (Fig. 3B ) patterns to those of healthy controls. Nevertheless, N1 amplitudes were significantly reduced in patients with schizophrenia relative to healthy controls in response to both the S1 [F(1,24.9) = 7.3, P = 0.012] and S2 [F(1,25.0) = 22.8, P 5 0.001] stimuli (Fig. 3C) . Conversely, the P2 responses in patients with schizophrenia were significantly enhanced to the S2 [F(1,25.0) = 9.5, P = 0.005], but not the S1 stimulus [F(1,24.7) = 2.0, P = 0.17]. Patients with schizophrenia also showed reduced CNV amplitude [F(1,25.2) = 19.9, P 5 0.001], and S2 differences for N1 [F(1,20.5) = 4.7, P = 0.04] remained significant after covariation for CNV, with P2 differences retaining trend level significance [F(1,25.9) = 3.7, P = 0.06]. Patients with schizophrenia showed a S1 P2b peak that was not present in healthy controls, reflected in a significant between-group difference during the 375-400 ms time frame [F(1,24.6) = 8.1, P = 0.009].
Corresponding deficits in the initial sensory response were reflected in the time-frequency analysis, and included significant reductions in ITC across the y/a frequency ranges to both S1 [F(1,22.0) = 10.09, P = 0.004] and S2 stimuli [F(1,22.4) = 5.8, P = 0.025] (Fig. 3D) and in y/apower to the S1 stimulus [F(1,22.6) = 7.2, P = 0.014] (Fig.  3E) . Similar results were obtained if results were confined to y-frequency range. In addition, patients with schizophrenia showed reduced y-ITC [F(1,22.6) = 11.9, P = 0.002] and b-ERD [F(1,22.0) = 6.6, P = 0.018] (Fig. 3E) during the motor-preparation interval.
Relationship between event-related potential and time-frequency measures
After control for group status, N1 to S1 strongly correlated with y/a-ITC to the S1 (partial r = À0.59, P = 0.001) and the CNV correlated with b-ERD during the motor preparation interval (partial r = À0.38, P = 0.053) at a trend level, without a Group Â ITC or power interaction (all P 4 0.17), suggesting similar mechanisms.
NMDAR mechanisms
The role of NMDAR dysfunction in auditory plasticity deficits was evaluated in patients with schizophrenia (n = 21), who received three auditory plasticity sessions repeated in 1-week intervals, paired with either D-serine or placebo, which were administered in an interleaved fashion across subjects (Table 1 patients with schizophrenia who participated in the blinded study, while ERP/time-frequency were analysed from all subjects.
On their initial treatment day, patients with schizophrenia received either placebo or D-serine. No significant difference in JND was observed between these two conditions [placebo: 13.1 AE 2.1%; D-serine: 13.0 AE 1.0%; This effect was driven primarily by a highly significant between-session improvement in within-session plasticity (change from trials 20-30 versus 70-80) only for those subjects who received D-serine in two consecutive sessions [paired t(8) = 3.1, P = 0.016, Fig. 4A ]. By contrast, subjects showed non-significant worsening in the second session if they received either placebo followed by D-serine [paired t(8) = 0.9, P = 0.39] or D-serine followed by placebo [paired t (7) A similar statistical result was obtained if data were collapsed across the placebo/D-serine and D-serine/placebo conditions. As a result of the differential plasticity, JND thresholds between treatment conditions also showed a highly significant [F(2,47.9) = 8.3, P = 0.001] treatment effect (Fig. 4B) , with a significant difference between those receiving repeated D-serine versus those receiving either placebo treatment or D-serine given for one session only (post hoc P = 0.006). Furthermore, following two consecutive D-serine treatments, JND thresholds for patients with schizophrenia were no longer significantly different from healthy controls (post hoc P = 0.36). Similar differences were seen across the full (n = 21) sample [F(2,234.6) = 5.0, P = 0.01].
Neurophysiological effects of NMDAR
D-serine treatment did not significantly affect the sensory ERP ( Fig. 4C and D) or sensory time-frequency responses (Fig. 4E) . However, significant overall statistical effects were observed for y-ITC during the motor-preparation interval [F(2,46 .2) = 5.0, P = 0.01] (Fig. 4F) and b-power across the retention and motor preparation intervals [F(2,59.8) = 3.6, P = 0.034].
These overall effects were driven primarily by significant differences between the consecutive session D-serine and the placebo groups for both y-ITC [F(1,27) = 4.5, P = 0.043] (Fig. 4F) and b-power [F(1,53.4) = 7.0, P = 0.011]. In addition, after control for group status, y-ITC during the motor-preparation interval correlated significantly with final JND threshold (partial r = À0.32, P = 0.013, Fig.  4G ), without a Group Â ITC interaction (P 4 0.99). Although no significant NMDAR effects were observed on N1 amplitude, N1 to S1 stimuli correlated significantly with auditory plasticity (r = 0.32, P = 0.015) across all subjects/sessions, without a Group Â N1 interaction (P 4 0.40). N1 correlations with plasticity remained significant at a trend level after control for group status (partial r = 0.24, P = 0.07). No significant correlations were seen for plasticity or JND with P2 or CNV.
Mismatch negativity
Finally, to evaluate the degree to which D-serine-induced behavioural changes were associated with physiological improvement, MMN was obtained prior to and following training sessions to both 'trained' tones (i.e. those corresponding to ones used in the auditory titration during that session), and 'untrained' tones (i.e. those corresponding to different base frequencies).
As expected, patients with schizophrenia had significant baseline (pre-training) deficits in MMN generation compared to healthy controls [F(3,83 .1) = 4.8, P = 0.015)] (Fig. 5A and B) , with no significant difference in MMN by tone type [F(2,171.1) = 2.0, P = 0.14] or between patient groups. Patients with schizophrenia receiving two consecutive sessions of D-serine had a significantly larger pre-post change to trained tones than those receiving placebo [F(1,33) = 6.0, P = 0.02] (Fig. 5B) . By contrast, other groups showed a tendency toward worsening. Across patients with schizophrenia, changes in MMN to trained tones correlated significantly with behavioural improvements in JND (r = À0.34, P = 0.034, n = 40, Fig. 5C ), and within session plasticity correlated with post-training MMN (r = 0.31, P = 0.017).
Discussion
Schizophrenia is associated with deficits not only in ongoing cognitive performance, but also in ability to learn new information and improve performance with training ('plasticity'), which limits the ability to benefit from rehabilitation approaches. While neural mechanisms underlying cognitive dysfunction have been extensively studied, neural mechanisms underlying plasticity deficits have been evaluated to a much lesser degree. Here we utilize an auditory plasticity paradigm that has been well validated in developmental dyslexia (Ahissar, 2001) both to investigate integrity of auditory plasticity in schizophrenia and to evaluate underlying neurophysiological mechanisms.
Principal findings are as follows: first, as opposed to developmental dyslexia in which reverse hierarchical deficits are observed primarily in the 'fixed' base tone condition and the P2 component, reflecting primarily top-down impairment, patients with schizophrenia show deficits across random and fixed conditions, suggesting dysfunction across multiple levels of the neuroaxis (Fig. 6) (Ahissar et al., 2009; Leitman et al., 2010) .
Areas implicated in patients with schizophrenia include auditory sensory regions, which serve as generators for processes such as auditory N1 and MMN and which participate in both the random and fixed condition; and frontoparietal 'task' and 'working memory' regions that are engaged to a greater degree during random than fixed (Daikhin and Ahissar, 2015) and may be particularly involved in CNV generation (Chennu et al., 2013) . Impaired generation of not only auditory sensory regions, but also 'top-down' cognitive control regions is consistent with distributed hierarchical models of schizophrenia, as proposed previously (Leitman et al., 2010) . The findings are consistent with structural neuroimaging findings showing sulcal thickness reductions across frontal, parietal, and superior temporal brain regions (Wagstyl et al., 2016) .
Behavioural study
As in previous studies in developmental dyslexia and healthy controls (Ahissar et al., 2006; Oganian and Ahissar, 2012) , impaired auditory plasticity correlated highly with deficits in higher-order auditory-dependent processes such as working memory (P 5 0.0001) and reading (P = 0.0004) that are crucial for social and occupational function. In addition, we showed a robust across-group relationship between impaired auditory plasticity and impaired auditory emotion recognition (P 5 0.0001), which is a critical component of social cognitive impairment in schizophrenia (Green et al., 2000 (Green et al., , 2015 Edwards et al., 2001) . Ahissar (2015) and Javitt and Sweet (2015) . We show an auditory cortex pyramidal cell receiving bottom-up input from the thalamic medial geniculate nucleus (MGN), parvalbumin (PV), and somatostatin (SST) interneurons (Womelsdorf et al., 2014) , which in-turn receive top-down input from intraparietal or frontoparietal neurons (inset). NMDAR, noted by an asterisk, appears to be involved at multiple levels.
The present study builds upon previous investigations of auditory dysfunction in schizophrenia, as well as prior auditory remediation literature. Although sensory processes were once considered 'intact simple functions,' an expanding literature suggests that auditory deficits not only are robust in schizophrenia, but contribute significantly to higher order dysfunction (Leitman et al., 2007; . The present findings extend these results to demonstrate impairments in auditory plasticity as well, and correlations between impairments in both plasticity and higher order processes.
Neurophysiological mechanisms
As expected, patients with schizophrenia showed significant impairment in neurophysiological responses to both the reference (S1) and test (S2) tones in the fixed condition. N1 and MMN deficits were consistent with well-described early sensory processing impairments in schizophrenia (Friedman et al., 2012; Green et al., 2012; Light and Swerdlow, 2015) , but differed from the pattern observed in developmental dyslexia (Jaffe-Dax et al., 2015) . Both N1 and MMN deficits correlated with impaired plasticity, and suggest additional sensory level contributions to auditory plasticity deficits in patients with schizophrenia. Along with deficits in sensory measures, patients with schizophrenia showed deficits in CNV, which is known to be both deficient in schizophrenia (Small and Small, 1971 ) with a larger CNV related to improved performance on this task (Cohen et al., 2013) . P2 enhancement appeared to be secondary to the absence of a CNV in patients with schizophrenia, although prior studies have localized P2 to parietal areas and suggested a role for P2 enhancement in attention (Crowley and Colrain, 2004) .
In the present study, however, no correlations were observed between performance and CNV. Correlations were observed with sensory measures, which likely reflects the fact that in the fixed condition, the 'task control' aspects are not rate-limiting for performance. Alternative versions stressing cognitive control, such as those involving dual tasks, manipulation of timing, presence of distractors, or other attentional modulations would likely show additional impairments reflecting frontoparietal control and emphasizing CNV contributions (Boehm et al., 2014) .
In time-frequency analyses, deficits corresponded to reductions in both power and ITC of low (y/a) frequency oscillatory activity during both the sensory and motorpreparation periods, similar to effects previously observed with the visual system in schizophrenia (Bickel et al., 2012; Dias et al., 2013) . Other auditory impairments in schizophrenia, such as reduced MMN generation, also have been mapped to impaired y generation ; Lee et al., submitted for publication), supporting recent increases in interest regarding the importance of low frequency oscillations in the pathophysiology of cognitive dysfunction in schizophrenia (Lisman et al., 2008; Womelsdorf and Everling, 2015) . Moreover, we hypothesize that deficits during the motor -preparation period may localize to intraparietal and frontoparietal regions (Daikhin and Ahissar, 2015) .
NMDAR mechanisms
Finally, deficits were significantly modulated by repeated administration of the NMDAR modulator D-serine. Effects of D-serine were observed not only on plasticity but also on early sensory level (MMN) and higher level (y-ITC, b-ERD) physiological measures, consistent with well-documented effects of NMDAR agonists on multiple cognitive domains. Over recent years, deficits in MMN generation have become among the most widely observed physiological impairments in schizophrenia (Umbricht and Krljes, 2005; Light et al., 2012; Erickson et al., 2016) . MMN has shown significant utility in early detection of at-risk individuals (Bodatsch et al., 2015) , for which Dserine may be therapeutic . The present report is consistent with our previous report demonstrating that deficits in MMN in schizophrenia are sensitive to NMDAR treatment (Kantrowitz et al., submitted for publication). Although the N1 is also known to be NMDAR sensitive (Umbricht et al., 2000) , we did not see a D-serine effect. However, in contrast to MMN, N1 is tied more specifically to stimulus detection than comparison.
Because D-serine is a low-potency NMDAR agonist, its specific clinical utility is likely limited. Nevertheless, the present findings suggest first that NMDAR agonists as a class may be useful in potentiating plasticity during auditory remediation training and, second, that the auditory plasticity paradigm may be useful in evaluating potential novel treatment approaches. In addition, while the large majority of NMDAR agonist studies in schizophrenia have utilized continuous treatment with NMDAR agonists for therapeutic intervention, the present study supports episodic (once weekly) intervention for cognition enhancement. Moreover, plasticity-based remediation targeting auditory deficits is reported to improve not only auditorylevel function, but also higher-level processes such as verbal working memory and global cognitive function Vinogradov et al., 2012) . In previous studies, alterations in neurophysiological responses were observed following $30-50 h of training (Popov et al., 2012; Dale et al., 2016) . A noteworthy result of the present study is that we observed neurophysiological improvement following only two sessions paired with an NMDAR agonist. Because of the different interventions, the comparability between the sets of findings is uncertain, and future studies are required to determine whether similar effects will be observed in combination with the types of targeted exercises that have been used previously for long-term auditory remediation.
Finally, an interesting result from the present study is that the magnitude of effect was significantly larger in patients with schizophrenia who received two consecutive days of D-serine than it was in those who only received an initial administration. Similar paradoxical effects have also been noted in rodent investigations, suggesting that greatest effects are on consolidation rather than initiation of longterm potentiation (Quartermain et al., 1994; Santini et al., 2001; Liu et al., 2014) . The time course of the present effects may be best explained by an emerging literature suggesting that long-term potentiation occurs in two different phases-an initial NMDAR-induced increase in AMPA receptor trafficking that occurs over minutes, followed by a delayed increase in NMDAR trafficking that occurs over hours (consolidation) (Watt et al., 2004 ).
An increase in NMDAR trafficking would also potentially account for the 'priming' effect observed in the present study whereby both physiological and behavioural effects were much larger following two consecutive treatments of D-serine than following a single day. Our results are also consistent with D-cycloserine studies suggesting efficacy only when an NMDAR agonist is given on the first session (Gottlieb et al., 2011) , and overall suggest the need for further investigations into the most effective timing of NMDAR-based intervention relative to plasticity-based treatment.
Limitations
Despite the overall significant results, several limitations must be considered. First, because of the limited number of task variations used, we were not able to investigate the potential roles of motivation, arousal, attention and alertness while performing the task. Future versions of the task are needed that explicitly control for these variables.
Second, patients with schizophrenia were relatively late in the course of illness and were receiving relatively high doses of antipsychotics and receiving anticholinergic medications, which may have affected the neurophysiological response (Adcock et al., 2009) . Although these medications have not been found to affect MMN generation (Umbricht et al., 1998 (Umbricht et al., , 1999 Friedman et al., 2012; , nevertheless, effects on either plasticity or neurophysiological responses during the auditory plasticity task cannot be excluded.
Third, despite highly significant improvement in plasticity and trained tone MMN, we did not train or demonstrate direct improvement in higher order functioning or carryover to other untrained tasks or MMN tones. Furthermore, the auditory plasticity task is optimized to evaluate underlying neurophysiological mechanisms, but may have only limited utility for repeated administration.
Fourth, due to the need to average across trials, our neurophysiological measures during the auditory plasticity task reflect performance across the whole session, as opposed to our more fine-tuned measures of within-session plasticity and JND.
Finally, although an overall D-serine treatment effect was observed, the comparison between patients with schizophrenia receiving two consecutive D-serine sessions versus one session was post hoc, had a limited sample-size, and included a mix of random/non-random and blind/unblind subjects, and thus needs to be replicated a priori.
Conclusions
In summary, the present study demonstrates that patients with schizophrenia show behavioural deficits in both fixed and random versions of auditory plasticity tasks, along with significant impairments in generation of the sensorydependent N1 potential and MMN, frontally dependent CNV and low frequency time-frequency, suggesting distributed dysfunction across multiple brain regions.
Moreover, plasticity was modulated by repeated intermittent administration of the NMDAR agonist D-serine, suggesting first that NMDAR dysfunction may contribute to the auditory plasticity impairments observed in schizophrenia, and second, that the auditory plasticity paradigm may be useful for development of novel approaches for reversal of cortical plasticity impairments in schizophrenia. Future reports should further assess the neural substrates of auditory plasticity deficits in schizophrenia utilizing parametric manipulations to differentially stress sensory versus frontoparietal control regions.
